MannKind Corp (MNKD)
4.305
+0.20
(+4.74%)
USD |
NASDAQ |
May 01, 14:25
MannKind Cash from Operations (Quarterly): 21.68M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 21.68M |
September 30, 2023 | 8.664M |
June 30, 2023 | 2.596M |
March 31, 2023 | 1.156M |
December 31, 2022 | -2.376M |
September 30, 2022 | -28.07M |
June 30, 2022 | -31.98M |
March 31, 2022 | -18.25M |
December 31, 2021 | -12.35M |
September 30, 2021 | -15.18M |
June 30, 2021 | -21.45M |
March 31, 2021 | -12.73M |
December 31, 2020 | 0.235M |
September 30, 2020 | -13.46M |
June 30, 2020 | -3.684M |
March 31, 2020 | -11.22M |
December 31, 2019 | -5.107M |
September 30, 2019 | -52.05M |
June 30, 2019 | -19.73M |
March 31, 2019 | -11.60M |
December 31, 2018 | 24.99M |
September 30, 2018 | -13.92M |
June 30, 2018 | -27.15M |
March 31, 2018 | -21.65M |
December 31, 2017 | -29.98M |
Date | Value |
---|---|
September 30, 2017 | -23.27M |
June 30, 2017 | -20.03M |
March 31, 2017 | 8.507M |
December 31, 2016 | -12.75M |
September 30, 2016 | -23.07M |
June 30, 2016 | -11.51M |
March 31, 2016 | -30.76M |
December 31, 2015 | -22.55M |
September 30, 2015 | -19.89M |
June 30, 2015 | -17.81M |
March 31, 2015 | 3.02M |
December 31, 2014 | -35.74M |
September 30, 2014 | 100.24M |
June 30, 2014 | -23.42M |
March 31, 2014 | -36.99M |
December 31, 2013 | -34.05M |
September 30, 2013 | -32.91M |
June 30, 2013 | -29.74M |
March 31, 2013 | -32.03M |
December 31, 2012 | -28.10M |
September 30, 2012 | -34.26M |
June 30, 2012 | -25.02M |
March 31, 2012 | -32.49M |
December 31, 2011 | -20.36M |
September 30, 2011 | -36.04M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-52.05M
Minimum
Sep 2019
21.68M
Maximum
Dec 2023
-11.23M
Average
-12.35M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.314M |
Palatin Technologies Inc | -10.48M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -6.541M |
Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -7.895M |
Cash from Financing (Quarterly) | 141.68M |
Free Cash Flow | -8.347M |
Free Cash Flow Per Share (Quarterly) | 0.0586 |
Free Cash Flow to Equity (Quarterly) | 20.34M |
Free Cash Flow to Firm (Quarterly) | 17.52M |
Free Cash Flow Yield | -0.69% |